4-(3-methoxypropoxy)-3-methylpicolinic acid - Names and Identifiers
4-(3-methoxypropoxy)-3-methylpicolinic acid - Physico-chemical Properties
Molecular Formula | C11H15NO4
|
Molar Mass | 225.24 |
Density | 1.177±0.06 g/cm3(Predicted) |
Boling Point | 386.2±37.0 °C(Predicted) |
pKa | 1.23±0.50(Predicted) |
Storage Condition | 2-8°C |
4-(3-methoxypropoxy)-3-methylpicolinic acid - Introduction
Rabeprazole Impurity 2 (Rabeprazole Impurity 2) is a chemical that is one of the impurities of the drug Rabeprazole. The following is its nature, use, preparation and safety information:
Nature:
Rabeprazole 2 is an organic compound with the chemical formula C18H21N3O3S. Its appearance is a white solid with ignitable properties. It has good solubility and can be dissolved in both water and organic solvents.
Use:
Rabeprazole Impurity 2 is mainly used as a reference substance for quality control and analytical methods of the drug Rabeprazole. It can be used to evaluate the impurity content in rabeprazole medicine and ensure the quality and stability of the medicine.
Preparation Method:
The preparation method of Rabeprazole Impurity 2 is usually carried out through organic synthetic chemical reactions. The specific preparation process can be adjusted according to actual needs. During the preparation process, attention should be paid to operating conditions and safety measures to prevent harm to the human body and the environment.
Safety Information:
There is a lack of detailed research and reporting on the safety information of Rabeprazole 2. As a chemical substance, users should comply with relevant safety regulations and take appropriate protective measures, such as wearing protective gloves, glasses, masks, etc. In case of accidental contact or ingestion, seek medical advice immediately and consult a professional doctor.
Summary:
Rabeprazole Impurity 2 is a reference substance for drug quality control. It is prepared by organic synthesis and has flammable properties. In use, the relevant safety regulations should be observed and the advice of a professional doctor should be consulted.
Last Update:2024-04-09 21:32:49